These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29438808)

  • 21. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
    O'Donnell DE; Hamilton AL; Webb KA
    J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
    Aliverti A; Rodger K; Dellacà RL; Stevenson N; Lo Mauro A; Pedotti A; Calverley PM
    Thorax; 2005 Nov; 60(11):916-24. PubMed ID: 15994253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary disease.
    Chen R; Chen R; Chen X; Chen L
    Intern Med J; 2014 Aug; 44(8):791-800. PubMed ID: 24860934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease.
    Verkindre C; Bart F; Aguilaniu B; Fortin F; Guérin JC; Le Merre C; Iacono P; Huchon G
    Respiration; 2006; 73(4):420-7. PubMed ID: 16484769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
    Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
    Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tiotropium induced bronchodilation and protection from dynamic hyperinflation is independent of extent of emphysema in COPD.
    Gelb AF; Taylor CF; Cassino C; Shinar CM; Schein MJ; Zamel N
    Pulm Pharmacol Ther; 2009 Jun; 22(3):237-42. PubMed ID: 19138754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO
    Ferguson GT; Karpel JP; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2701-2710. PubMed ID: 27843306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.
    van Noord JA; Aumann JL; Janssens E; Verhaert J; Smeets JJ; Mueller A; Cornelissen PJ
    Chest; 2006 Mar; 129(3):509-17. PubMed ID: 16537846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study).
    Watz H; Mailänder C; Baier M; Kirsten A
    BMC Pulm Med; 2016 Jun; 16(1):95. PubMed ID: 27301417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
    Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
    Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease.
    Beeh KM; Westerman J; Kirsten AM; Hébert J; Grönke L; Hamilton A; Tetzlaff K; Derom E
    Pulm Pharmacol Ther; 2015 Jun; 32():53-9. PubMed ID: 25956072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.
    Berton DC; Reis M; Siqueira AC; Barroco AC; Takara LS; Bravo DM; Andreoni S; Neder JA
    Respir Med; 2010 Sep; 104(9):1288-96. PubMed ID: 20580216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial.
    Ramírez-Venegas A; Velázquez-Uncal M; Aranda-Chávez A; Guzmán-Bouilloud NE; Mayar-Maya ME; Pérez Lara-Albisua JL; Hernández-Zenteno RJ; Flores-Trujillo F; Sansores RH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1753-1762. PubMed ID: 31496674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treadmill endurance during 2-year treatment with tiotropium in patients with COPD: a randomized trial.
    Cooper CB; Celli BR; Jardim JR; Wise RA; Legg D; Guo J; Kesten S
    Chest; 2013 Aug; 144(2):490-497. PubMed ID: 23558890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of long-acting dual bronchodilator therapy on exercise tolerance, dynamic hyperinflation, and dead space during constant work rate exercise in COPD.
    Stringer WW; Porszasz J; Cao M; Rossiter HB; Siddiqui S; Rennard S; Casaburi R
    J Appl Physiol (1985); 2021 Jun; 130(6):2009-2018. PubMed ID: 33914661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.
    Lee HY; Choi SM; Lee J; Park YS; Lee CH; Kim DK; Lee SM; Yoon HI; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2185-92. PubMed ID: 26508848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.